Breaking NewsIndian Beehive

SigTuple raised $4 M in extended Series C from SIDBI Venture

With the participation of current investors Endiya Partners and a few influential figures in the healthcare industry, the medical technology startup SigTuple has raised Rs 33 crore ($4 million) in its extended Series C round, which is being led by SIDBI Venture Capital.

Prior to this, in March 2023, the Bengaluru-based company raised $4.3 million in its Series C round, which was led by Accel and Endiya Partners. The company has so far raised more than $40 million.

SigTuple stated in a press release that it will use the additional funds to support regulatory clearances, broaden its product offering, and promote geographic expansion.

Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey, and Tathagato Dastidar founded SigTuple in 2015 with the goal of automating manual processes in clinical laboratories through the use of smart robotic microscopes powered by artificial intelligence.

With major players in the diagnostics industry as customers, SigTuple has concentrated on its flagship product, AI100, since 2020. The product is currently gaining significant traction in the Indian market.

Together with SigTuple, which uses Horiba Medical as a distribution channel in South Asia, the company has also expanded into Southeast Asia, the Middle East, North Africa, and plans to reach Europe and the Americas. AI100 was approved by the US FDA under 510(k) in September 2023, making SigTuple the first company in India and the third company worldwide to accomplish this for AI-assisted digital haematology.

 

 

Related Articles

Back to top button